Vertex Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | 156.1 | 126.3 | 194.3 | 146.1 | 186.5 | 105.8 | 77.4 | 20.5 | 22.2 | 21.5 | 20.6 | 48.8 | 41.5 | 36.7 | 26.7 | 22.9 | 20.4 | 26.4 | 21.6 | 24.1 | 27.5 | 22.8 | 23.0 | 22.6 | 25.2 | 27.2 | 26.1 | 29.3 | 27.2 | – | – | – | – | 31.7 | 27.4 | 29.4 | 26.4 | 28.8 | |
| 12.9 | 10.7 | 13.5 | 15.2 | 16.6 | 15.5 | 17.5 | 16.8 | 17.7 | 14.1 | 14.7 | 13.8 | 12.2 | 13.8 | 13.0 | 14.2 | 12.0 | 10.0 | 8.8 | 7.9 | 6.6 | 7.5 | 8.5 | 8.7 | 8.6 | 8.4 | 8.9 | 9.6 | 9.4 | 10.8 | 10.7 | 11.7 | 11.4 | 9.5 | 11.3 | 10.1 | 8.6 | 9.6 | 9.3 | 10.1 | |
| 17.8 | 13.6 | 16.2 | 17.4 | 21.1 | 18.8 | 17.3 | 16.2 | 17.1 | 9.7 | 10.1 | 9.4 | 8.4 | 9.4 | 9.7 | 10.2 | 8.8 | 7.2 | 6.3 | 5.7 | 4.9 | 5.6 | 6.2 | 6.1 | 5.8 | 5.4 | 5.7 | 5.9 | 5.5 | 6.0 | 5.9 | 8.2 | 7.8 | 6.4 | 7.6 | 6.7 | 5.8 | 6.2 | 5.9 | 6.3 | |
| 12.9 | 10.5 | 13.2 | 14.9 | 16.2 | 15.0 | 16.9 | 16.2 | 17.0 | 13.4 | 13.8 | – | – | 13.1 | – | – | – | 9.1 | – | – | – | 6.6 | – | – | – | 7.3 | – | – | – | 9.7 | – | – | 10.9 | 9.1 | – | – | – | 9.2 | – | – | |
| – | 249.3 | 75.5 | 79.0 | 2,064.1 | 362.3 | 676.5 | 176.7 | 60.8 | 58.0 | 54.5 | – | – | 34.8 | – | – | – | 17.1 | – | – | – | 17.0 | – | – | – | 14.6 | – | – | – | 20.8 | – | – | 223.9 | 207.1 | – | – | – | 22.8 | – | – | |
| 322.5 | 101.7 | 59.0 | 54.0 | 55.1 | 51.6 | 59.0 | 52.2 | 47.2 | 36.6 | 38.1 | 33.7 | 32.4 | 38.4 | 31.6 | 29.9 | 24.1 | 20.8 | 18.5 | 29.6 | 24.5 | 23.4 | 27.5 | 19.2 | 19.7 | 19.2 | 21.1 | 23.6 | 21.5 | 31.8 | 30.9 | – | – | – | – | 32.9 | 30.2 | 36.4 | 30.8 | 33.5 | |
| 0.3% | 1.0% | 1.7% | 1.9% | 1.8% | 1.9% | 1.7% | 1.9% | 2.1% | 2.7% | 2.6% | 3.0% | 3.1% | 2.6% | 3.2% | 3.3% | 4.1% | 4.8% | 5.4% | 3.4% | 4.1% | 4.3% | 3.6% | 5.2% | 5.1% | 5.2% | 4.7% | 4.2% | 4.6% | 3.1% | 3.2% | -1.1% | -1.1% | -0.9% | -1.0% | 3.0% | 3.3% | 2.8% | 3.2% | 3.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 87.1% | 87.6% | 89.8% | 89.1% | 89.0% | 88.9% | 87.6% | 87.3% | 86.9% | 86.6% | 86.7% | 86.6% | 86.6% | 86.8% | 87.2% | 87.7% | 88.0% | 88.1% | 88.1% | 87.9% | 87.9% | 88.1% | 88.0% | 88.1% | 88.0% | 87.9% | 88.0% | 87.9% | 87.8% | 87.2% | 86.9% | 86.4% | 86.1% | 86.1% | 86.0% | 86.1% | 86.3% | 86.3% | 86.3% | 86.0% | |
| -5.3% | 0.4% | 14.5% | 16.0% | 1.6% | 5.0% | -0.8% | 3.9% | 22.4% | 20.8% | 24.0% | 25.5% | 21.4% | 28.8% | 34.0% | 38.7% | 44.4% | 46.0% | 47.1% | 33.9% | 37.2% | 36.7% | 36.9% | 48.9% | 47.7% | 48.2% | 43.9% | 41.7% | 40.2% | 38.8% | 41.2% | -3.4% | -2.5% | -2.1% | -6.7% | 34.4% | 34.1% | 35.5% | 39.0% | 38.6% | |
| -13.5% | -6.8% | 8.6% | 12.1% | 8.5% | 10.6% | 9.4% | 15.8% | 22.9% | 68.8% | 66.0% | 64.1% | 59.2% | 28.3% | 31.4% | 38.5% | 44.9% | 43.7% | 43.1% | 29.8% | 30.5% | 30.9% | 30.8% | 38.3% | 37.6% | 37.2% | 35.4% | 35.4% | 35.9% | 36.7% | 39.5% | -4.7% | -4.5% | -4.9% | -8.9% | 31.9% | 31.3% | 32.8% | 35.4% | 34.9% | |
| 4.0% | 10.5% | 22.8% | 28.2% | 30.1% | 30.0% | 29.6% | 32.1% | 37.5% | 38.5% | 38.5% | 40.9% | 37.7% | 35.9% | 41.2% | 47.3% | 49.7% | 48.2% | 47.5% | 26.6% | 26.9% | 31.8% | 30.8% | 45.4% | 43.8% | 44.0% | 42.3% | 40.8% | 43.6% | 33.8% | 34.7% | -13.2% | -12.2% | -8.9% | -11.3% | 30.6% | 28.5% | 26.5% | 30.3% | 30.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -18.6% | -8.6% | 10.4% | 13.8% | 10.9% | 12.9% | 9.3% | 15.3% | 22.0% | 47.3% | 45.6% | 43.7% | 40.8% | 19.3% | 23.4% | 27.7% | 33.1% | 31.2% | 30.8% | 21.7% | 22.8% | 23.2% | 22.5% | 26.8% | 25.1% | 23.9% | 22.6% | 21.8% | 21.0% | 20.6% | 21.7% | -3.3% | -3.1% | -3.3% | -6.0% | 21.2% | 21.2% | 21.2% | 22.4% | 21.8% | |
| -8.6% | -4.0% | 5.9% | 7.8% | 6.1% | 7.4% | 5.7% | 9.6% | 14.0% | 33.6% | 32.9% | 31.5% | 28.5% | 14.1% | 17.0% | 20.4% | 23.8% | 23.1% | 22.8% | 16.3% | 17.2% | 17.4% | 17.2% | 20.5% | 19.6% | 18.3% | 17.2% | 16.5% | 16.0% | 15.9% | 16.8% | -2.4% | -2.2% | -2.4% | -4.3% | 15.1% | 14.8% | 15.1% | 16.4% | 16.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 69 | -378 | -486 | -680 | -818 | -1,079 | -1,418 | -1,568 | -1,905 | -2,078 | -2,823 | – | – | -3,071 | – | – | – | -5,946 | – | – | – | -6,715 | – | – | – | -10,415 | – | – | – | -10,285 | – | – | -5,459 | -4,477 | – | – | – | -5,005 | – | – | |
| – | -5.3 | -1.4 | -1.7 | -45.4 | -10.5 | -23.6 | -6.5 | -2.4 | -2.9 | -3.4 | – | – | -2.0 | – | – | – | -1.8 | – | – | – | -2.3 | – | – | – | -2.3 | – | – | – | -2.2 | – | – | -10.5 | -9.2 | – | – | – | -1.0 | – | – | |
| 46.0% | 46.2% | 57.1% | 56.8% | 56.4% | 57.6% | 61.5% | 62.6% | 63.5% | 71.0% | 72.2% | 72.1% | 69.9% | 73.2% | 72.7% | 73.6% | 72.0% | 73.9% | 74.1% | 75.2% | 75.5% | 75.2% | 76.5% | 76.6% | 78.0% | 76.7% | 76.1% | 76.0% | 76.0% | 77.3% | 77.5% | 73.4% | 70.3% | 72.8% | 72.1% | 71.5% | 69.7% | 71.4% | 73.1% | 73.8% | |
| 0.7 | 0.6 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | – | – | 0.0 | – | – | – | 0.0 | – | – | – | 0.0 | – | – | – | 0.0 | – | – | – | 0.0 | – | – | 0.0 | 0.0 | – | – | – | 0.0 | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.91 | -0.46 | 0.70 | 1.02 | 0.78 | 1.03 | 0.87 | 1.61 | 2.49 | 8.07 | 8.28 | 8.53 | 8.23 | 4.49 | 5.73 | 7.90 | 10.19 | 10.31 | 10.55 | 7.63 | 8.38 | 9.11 | 9.50 | 12.35 | 12.61 | 12.76 | 12.52 | 12.92 | 13.31 | 13.87 | 15.39 | -1.90 | -1.84 | -2.06 | -3.81 | 14.05 | 14.27 | 15.44 | 16.93 | 17.23 | |
| 6.78 | 6.87 | 8.12 | 8.47 | 9.17 | 9.69 | 9.34 | 10.14 | 10.89 | 11.73 | 12.55 | 13.30 | 13.90 | 15.88 | 18.29 | 20.51 | 22.69 | 23.59 | 24.49 | 25.61 | 27.45 | 29.47 | 30.82 | 32.28 | 33.53 | 34.31 | 35.37 | 36.50 | 37.05 | 37.83 | 39.00 | 40.04 | 40.70 | 42.29 | 42.77 | 44.11 | 45.51 | 47.01 | 47.82 | 49.37 | |
| 4.89 | 5.40 | 6.77 | 7.42 | 7.21 | 7.95 | 9.40 | 10.50 | 11.30 | 17.07 | 18.15 | 19.51 | 20.17 | 23.22 | 24.52 | 28.55 | 30.80 | 33.02 | 34.29 | 35.23 | 36.70 | 39.30 | 42.29 | 46.13 | 50.21 | 53.45 | 55.44 | 59.41 | 63.36 | 67.38 | 71.03 | 57.24 | 59.89 | 62.99 | 63.57 | 66.34 | 67.23 | 72.88 | 75.54 | 79.19 | |
| 0.27 | 0.72 | 1.85 | 2.39 | 2.76 | 2.90 | 2.76 | 3.26 | 4.08 | 4.52 | 4.84 | 5.44 | 5.23 | 5.70 | 7.53 | 9.71 | 11.28 | 11.38 | 11.64 | 6.81 | 7.39 | 9.37 | 9.50 | 14.64 | 14.70 | 15.08 | 14.95 | 14.90 | 16.14 | 12.79 | 13.55 | -5.30 | -4.96 | -3.75 | -4.85 | 13.52 | 12.95 | 12.47 | 14.48 | 14.85 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.